A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Graft Versus Host Disease · Graft Vs Host Disease · Hematologic Malignancy

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Doris Ponce, MD) · 646-608-3739
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Doris Ponce, MD) · 646-608-3739
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Doris Ponce, MD) · 646-608-3739
  • Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack, New York, United States

    Contact: Study coordinator (Doris Ponce, MD) · 646-608-3739
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Doris Ponce, MD) · 646-608-3739
  • New York University (Data Collection Only), New York, New York, United States

    Contact: Study coordinator (Jingmei Hsi, MD) · 646-501-4848
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Doris M Ponce, MD) · 646-608-3739
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre, New York, United States

    Contact: Study coordinator (Doris Ponce, MD) · 646-608-3739
מובילי המחקר
  • Doris Ponce, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center